Norbrook Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NORBROOK, and what generic and branded alternatives to NORBROOK drugs are available?
NORBROOK has two approved drugs.
Summary for Norbrook
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Norbrook
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norbrook | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 070892-001 | Aug 26, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Norbrook | METHOTREXATE SODIUM | methotrexate sodium | INJECTABLE;INJECTION | 088648-001 | May 9, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
